Dow Up 0.07% Nasdaq Up 0.61%

Oncothyreon Inc (ONTY)

-NasdaqGS
1.86 Up 0.17(10.06%) Nov 26, 4:00PM EST
|After Hours : 1.86 0.00 (0.00%) Nov 26, 4:36PM EST
Prev Close:1.69
Open:1.69
Bid:1.84 x 3000
Ask:1.98 x 10000
1y Target Est:3.67
Beta:N/A
Next Earnings Date:N/A
Day's Range:1.68 - 1.87
52wk Range:1.52 - 4.08
Volume:1,679,763
Avg Vol (3m):644,560
Market Cap:170.29M
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ONTY

Comparison

Symbol% ChgMkt Cap
ONTYUp 10.06%170.29M
GSKUp 0.52%111.83B
RHHBYUp 0.54%254.20B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:08-May-95

Analysts

Annual EPS Est (Dec-14) :-0.40
Quarterly EPS Est (Dec-14) :-0.09
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oncothyreon Inc, a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer. Its product candidate includes Tecemotide, a vaccine for the treatment of non-small cell lung cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback